Neuronetics Inc(STIM) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 30 at 7:44 PM ET (Korea 10/31 08:44)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.44 | Insider Own | 62.1% | Shs Outstand | 76.2M | Perf Week | 6.64% |
| Market Cap | 0.17B | Forward P/E | - | EPS next Y | 19.82% | Insider Trans | 1.34% | Shs Float | 28.9M | Perf Month | 1.35% |
| Enterprise Value | 0.24B | PEG | - | EPS next Q | -0.09 | Inst Own | 29.73% | Short Float | 24.97% | Perf Quarter | 4.17% |
| Income | -0.03B | P/S | 1.11 | EPS this Y | 40.95% | Inst Trans | -9.96% | Short Ratio | 4.48 | Perf Half Y | 11.39% |
| Sales | 0.16B | P/B | 9.6 | EPS next 5Y | 26.75% | ROA | -22.87% | Short Interest | 7.21M | Perf YTD | 63.04% |
| Book/sh | 0.23 | P/C | 6.81 | EPS past 3/5Y | 24.64% 16.51% | ROE | -135.26% | 52W High | -34.59% ($3.44) | Perf Year | -16.67% |
| Cash/sh | 0.33 | P/FCF | - | Sales past 3/5Y | 31.76% 24.81% | ROIC | -30.67% | 52W Low | 181.25% ($0.80) | Perf 3Y | 108.33% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 61.06% | Gross Margin | 47.56% | Volatility(W/M) | 8.28% 6.14% | Perf 5Y | -56.73% |
| Dividend TTM | - | EV/Sales | 1.53 | Sales Y/Y TTM | 39.59% | Oper. Margin | -14.74% | ATR (14) | 0.15 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.69 | EPS Q/Q | 69.26% | Profit Margin | -19.62% | RSI (14) | 50.05 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.88 | Sales Q/Q | 9.08% | SMA20 | 6.89% ($2.1) | Beta | 1.35 | Target Price | $5.75 |
| Payout | - | Debt/Eq | 4.85 | Earnings | 2026/11/4 | SMA50 | -10.79% ($2.52) | Rel Volume | 0.68 | Prev Close | $2.38 |
| Employees | 658 | LT Debt/Eq | 4.56 | EPS/Sales Surpr. | 59.35% 3.47% | SMA200 | 20.15% ($1.87) | Avg Volume(3M) | 1.61M | Price | $2.25 |
| IPO | 2018/6/28 | Option/Short | Yes/Yes | Trades | 3779 | Volume | 1,089,358 | Change | -5.46% |
🧠 Neuronetics is a U.S. medical device company that develops and sells transcranial magnetic stimulation-based neuropsychiatric treatment systems. Its flagship product, NeuroStar, is a treatment platform that delivers magnetic fields to the brain in a non-invasive manner for mental illnesses such as major depressive disorder, with psychiatric clinics serving as its main customers. Recently, the company has also expanded its business to include a treatment center network.
Over the past 1 year, roughly in the middle
35% below its 1-year high.
Traded less than usual. That is 68% of its average volume.
Next earnings report: November 4
4 days to go.
STIM has a sound balance sheet but weak earning power
Of every $100 in sales, $14.74 is lost.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +41.0% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $111. Peers typically go for $143.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -56.7%. The S&P 500 did +65% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Short interest is a burden
25.0% of the float is sold short.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #79 of 142 in the industry
Based on market cap of $171M.
RXST#77 RxSight Inc $203M PER - 
INGN#78 Inogen Inc $182M PER - STIM#79 Neuronetics Inc $171M PER - 
MXCT#80 MaxCyte Inc $164M PER - 
QTRX#81 Quanterix Corp $137M PER - 
FAQ
What kind of company is STIM?
STIM belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of STIM?
The market cap of STIM is approximately $171M, ranking 4,120 within its sector.
What is the 52-week high and low for STIM?
STIM has recorded a 52-week high of $3.44 and a low of $0.80.
